To clarify whether in human cancers antigen-experienced Teff or memory Tconv contribute to the Treg repertoire in vivo, we compared the TCR repertoires of antigen-experienced TA-specific CD4+Teff clones and Treg in PB of breast cancer patients. This evidence concerns the gene CD4 and breast carcinoma.